Casein Kinase 1δ/ε Inhibitor, PF670462 Attenuates the Fibrogenic Effects of Transforming Growth Factor-β in Pulmonary Fibrosis-Reference-Cited by-同舟云学术

Casein Kinase 1δ/ε Inhibitor, PF670462 Attenuates the Fibrogenic Effects of Transforming Growth Factor-β in Pulmonary Fibrosis

Published:2018-07-10 Issue: Volume:9 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Keenan Christine R.,Langenbach Shenna Y.,Jativa Fernando,Harris Trudi,Li Meina,Chen Qianyu,Xia Yuxiu,Gao Bryan,Schuliga Michael J.,Jaffar Jade,Prodanovic Danica,Tu Yan,Berhan Asres,Lee Peter V. S.,Westall Glen P.,Stewart Alastair G.

Funder

National Health and Medical Research Council

Australian Research Council

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference59 articles.

1. Induction of heart valve lesions by small-molecule ALK5 inhibitors.;Anderton;Toxicol. Pathol.,2011

2. An inhibitor of casein kinase I epsilon induces phase delays in circadian rhythms under free-running and entrained conditions.;Badura;J. Pharmacol. Exp. Ther.,2007

3. Epithelial-mesenchymal transition in lung development and disease: does it exist and is it important?;Bartis;Thorax,2014

4. Authors’ response: epithelial-mesenchymal Transition (EMT) is a common molecular programme in epithelial cells which can be triggered by injury.;Bartis;Thorax,2014

5. TGF-beta signaling in fibrosis.;Biernacka;Growth Factors,2011

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatocyte-Specific Casein Kinase 1 Epsilon Ablation Ameliorates Metabolic Dysfunction–Associated Steatohepatitis by Up-Regulating Tumor Necrosis Factor Receptor–Associated Factor 3 in Mice;The American Journal of Pathology;2024-08

2. Multifaceted TGF‐β signaling, a master regulator: From bench‐to‐bedside, intricacies, and complexities;Cell Biology International;2023-10-19

3. Cryptotanshinone affects HFL-1 cells proliferation by inhibiting cytokines secretion in RAW264.7 cells and ameliorates inflammation and fibrosis in newborn rats with hyperoxia induced lung injury;Frontiers in Pharmacology;2023-07-25

4. Anti-fibrotic strategies and pulmonary fibrosis;Advances in Pharmacology;2023

5. Circadian clock-based therapeutics in chronic pulmonary diseases;Trends in Pharmacological Sciences;2022-12